Reply to M. Sorigue et al

Affiliations

¹ Sandra Lockmer, MD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Bjørn Østenstad, MD, PhD, Oslo University Hospital, Oslo, Norway; Hans Hagberg, MD, PhD, Academic Hospital, Uppsala, Sweden; Harald Holte, MD, PhD, Oslo University Hospital, Oslo, Norway; Björn Engelbrekt Wahlin, MD, PhD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Karin Fahl Wader, MD, PhD, St Olavs Hospital, Trondheim, Norway; Karin Ekström Smedby, MD, PhD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Peter Brown, MD, PhD, Rigshospitalet, Copenhagen, Denmark; and Eva Kimby, MD, PhD, Karolinska Institutet, Stockholm, Sweden.

Comment

Sandra Lockmer et al. J Clin Oncol. 2019.

. 2019 Mar 20;37(9):759-760.

doi: 10.1200/JCO.18.02362. Epub 2019 Feb 8.

¹ Sandra Lockmer, MD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Bjørn Østenstad, MD, PhD, Oslo University Hospital, Oslo, Norway; Hans Hagberg, MD, PhD, Academic Hospital, Uppsala, Sweden; Harald Holte, MD, PhD, Oslo University Hospital, Oslo, Norway; Björn Engelbrekt Wahlin, MD, PhD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Karin Fahl Wader, MD, PhD, St Olavs Hospital, Trondheim, Norway; Karin Ekström Smedby, MD, PhD, Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital, Stockholm, Sweden; Peter Brown, MD, PhD, Rigshospitalet, Copenhagen, Denmark; and Eva Kimby, MD, PhD, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.
Lockmer S, Østenstad B, Hagberg H, Holte H, Johansson AS, Wahlin BE, Wader KF, Steen CB, Meyer P, Maisenhølder M, Smedby KE, Brown P, Kimby E. Lockmer S, et al. J Clin Oncol. 2018 Oct 4:JCO1800262. doi: 10.1200/JCO.18.00262. Online ahead of print. J Clin Oncol. 2018. PMID: 30285560
Is Longer Progression-Free Survival a Goal Worth Pursuing in Follicular Lymphoma?
Sorigue M, Sancho JM. Sorigue M, et al. J Clin Oncol. 2019 Mar 20;37(9):758. doi: 10.1200/JCO.18.01761. Epub 2019 Feb 8. J Clin Oncol. 2019. PMID: 30735429 No abstract available.